(Q54329529)
Statements
A phase II trial evaluating the clinical and immunologic response of HLA-A2(+) non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide. (English)
Athanasios Kotsakis
Elisavet Papadimitraki
Eleni Kyriaki Vetsika
Despoina Aggouraki
Eleftheria Kleio Dermitzaki
Dora Hatzidaki
Nikolaos Kentepozidis
Dimitris Mavroudis
Vassilis Georgoulias
5 August 2014
86
1
59-66